Cutting edge: conventional dendritic cells are the critical APC required for the induction of experimental cerebral

Saskia deWalick1, Fiona H Amante, Karli A McSweeney

  • 1Queensland Institute of Medical Research, Herston, Australia.

Insights

Conventional dendritic cells, not plasmacytoid dendritic cells, are crucial for initiating T cell responses that cause experimental cerebral malaria (CM). This finding impacts malaria vaccine development and CM treatment strategies.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Pathology

Background:

  • Cerebral malaria (CM) is a severe complication of Plasmodium falciparum infection, leading to high rates of illness and death, particularly in children and nonimmune individuals.
  • While T cells are known to mediate CM pathology, the specific antigen-presenting cells (APCs) initiating these responses remain unidentified.

Purpose of the Study:

  • To identify the specific subsets of antigen-presenting cells (APCs) responsible for initiating T cell responses and immunopathology in experimental cerebral malaria (CM).

Main Methods:

  • Utilized a mouse model of experimental CM to investigate the roles of different dendritic cell subsets in initiating malaria-specific CD4+ T cell responses.
  • Compared the effects of conventional dendritic cells (cDCs) and plasmacytoid dendritic cells (pDCs) on the development of CM.

Main Results:

  • Conventional dendritic cells (cDCs) were found to be essential for inducing malaria parasite-specific CD4+ T cell responses.
  • Plasmacytoid dendritic cells (pDCs) were not required for the induction of these T cell responses or the development of experimental CM.

Conclusions:

  • Conventional dendritic cells (cDCs) play a critical role in initiating the immune responses that lead to experimental cerebral malaria (CM).
  • These findings suggest that targeting cDCs could be a viable strategy for developing new malaria vaccines and therapies for CM.